Home | Welcome to Contract Pharma   
Last Updated Saturday, November 22 2014
Print

Topics - Manufacturing


Refine by Date:
From: To:
Published November 21, 2014
Increased production capacity to support maturing biologics pipeline Read More »
Published November 21, 2014
Expands capacity for immunology and oncology pipelines Read More »
Published November 20, 2014
Lonza to manufacture anti-cancer drug at Nansha and Visp facilities Read More »
Published November 20, 2014
Aims to better support customers in the region Read More »
Published November 20, 2014
Incorporates multiple technologies aimed at greater speed and efficiency Read More »
Published November 19, 2014
Completes remediation following an environmental deviation Read More »
Published November 19, 2014
Implements Version V3.1.6 at its largest manufacturing facility Read More »
Published November 14, 2014
Lusomedicamenta provides access to new markets Read More »
Published November 14, 2014
The investment, upwards of $900 million, will support multiple therapies Read More »
Published November 14, 2014
Adds global particle size engineering technologies Read More »
Published November 7, 2014
Revenues climb 55% in the quarter Read More »
Published October 31, 2014
To produce commercial quantities of a second biologic at Lonza’s Portsmouth facility Read More »
Published October 30, 2014
Adds capabilities for heat or cold blending for large volumes Read More »
Published October 29, 2014
Adds high-speed filling center for large-scale production Read More »
Published October 23, 2014
Contract manufacturing market has grown 10% the past three years Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On